Germany Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Use GarageBand in Just 1 Hour Learn to create music in GarageBand and become the Beethoven you've wanted to be. This online course is just $30. Sign up today! From our sponsors

Germany Pharmaceuticals and Healthcare Report Q4 2013 Aug 21st 2013, 00:00 Price: $ 1295   BMI View: The Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) legislation will constrict drug companies' revenue-earning opportunities in Germany. While the law has focussed on the regulation of the pricing of newly approved drugs relative to their benefit over already-existing therapies - hitting companies hard - the government is now clamping down on prices set by drug companies back in Germany's free pricing era. Headline Expenditure Projections ? Pharmaceuticals: EUR38.89bn (US$49.39bn) in 2012 to EUR37.93bn (US$50.45bn) in 2013; -2.5% in local currency terms and 2.2% in US dollar terms. ? Healthcare: EUR291.82bn (US$3970.61bn) in 2012 to EUR297.32bn (US$395.43bn) in 2013; +1.9% in local currency terms and +6.7% in US dollar terms. ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/268324.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions